Compare Heima (HEI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heima vs Enzyme — how do they compare? Heima trades at Rp1,966 (market cap Rp190,45M, Rp336,34M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Heima is the larger of the two by market cap, and Heima's supply is capped (97,8M / 100M HEI (98%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Heima for 12 Days and Enzyme for 28 Days on average.
| HEI | MLN | |
|---|---|---|
Market Cap | Rp190,45M | Rp134,13M |
Volume (24h) | Rp336,34M | Rp104,56M |
Circulating Supply | 97,8M / 100M HEI (98%) | 3,3M MLN |
Typical Hold Time | 12 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heima (HEI) is trading at Rp1,874.82 with a market cap of Rp180.39 million, showing a bullish technical signal supported by moving averages. The token is near full circulation at 98%, with a short average hold time of 12 days. Current price sits between support at Rp1,753 and resistance at Rp2,195, indicating potential for upward movement if bullish momentum holds.
Overall outlook is cautiously optimistic due to technical strength, but limited fundamental updates and low liquidity pose risks. Key opportunities include breakout potential above resistance, while major risks involve high volatility and thin trading volumes. Investors should monitor for increased network activity or exchange listings to confirm sustainability.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Heima
As an evolution of the Litentry Network, the Heima Network was developed focusing on decentralized identity and privacy solutions. Building on this foundation, Heima expanded its scope to address cross-chain asset management and multi-chain interoperability.
Read more on HEI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
